Lion Tcr Is A Clinical Stage Biotechnology Company Based In Singaporefounded In 2015The Company Focuses On Developing And Commercializing T Cell Receptortcrt Cell Therapy To Address Life Threatening Viral Infections And Viral Related Cancersparticularly Those Prevalent In Asia The Company Specializes In Immunotherapy Treatmentsspecifically Tcr T Cell Therapywhich Utilizes The Immune System To Target Diseasestheir Personalized Tcr T Cell Therapy Aims To Treat Conditions Such As Hepatitis B Virus Related Hepatocellular Carcinomarecurrent Hepatocellular Carcinoma Post Liver Transplantand Chronic Hepatitis B Virus Infectionone Of Their Key Products Is Gzl 016An Mrna Based Tcr T Cell Therapy For Hepatocellular Carcinomawhich Has Received Approval From The China Nmpa Lion Tcr Operates A Manufacturing Facility That Adheres To Good Manufacturing Practicegmpguidelinesensuring High Quality Clinical Productsthe Company Has Raised $64 3 Million In Funding From Various Investors And Has Filed Several Patents Related To Immunology And Adoptive T Cell Therapy
No conferences found for this company.
| Company Name | Lion Tcr Pte Ltd |
| Country |
Singapore
|
| Address | N/A |
| Telephone | N/A |
| N/A |
